ARCHIVES

Carbone Names NCI Clinical Director, Rauscher shuffles Treatment Activities

This article is from The Cancer Letter archive.

Vol. 01 No. 30 | August 30, 1974

Download PDF Visit The Full Archive

Related Articles

Endostatin Enters Phase II Trial For Neuroendocrine Tumors.

December 14, 2001

In Brief: Cancer Panel to Meet Sept. 30 In Boston; House Passes Money Bill, With 41.347 Billion For NCI

August 15, 1986

Opening Shots Fired In 10 Year Defense of Cancer Program, Launching Of Effort To Continue, Expand It

September 19, 1980

Xeloda, Taxotere, Herceptin Combination May Benefit Invasive Breast Cancer

January 25, 2008

DePinho Explains Tenure Decision,Professors Dispute Key Details

May 30, 2014

Former BMS Executive Bodnar Indicted.

April 25, 2008